XLV Stock Recent News
XLV LATEST HEADLINES
The Investment Committee give you their top stocks to watch for the second half.
Healthcare led July job gains with 55,000 new positions, as most other U.S. sectors showed little to no growth. Tap ETFs like XLV and VHT.
Investing in healthcare has long been a cornerstone of defensive, long-term growth strategies. It is, after all, a massive and expanding segment of the global economy.
Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.
Jared Holz, Mizuho health care sector strategist, joins 'The Exchange' to discuss the pain in the health care sector and if there are any opportunity plays within.
'The Big Money Show' panel discusses President Donald Trump's pharmaceutical tariff strategy.
The life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients for longer periods. Investors pay low fees to hold XLV, since the expense ratio of this financial instrument is only 0.08%. For this year, the top ten holdings of XLV expect a median revenue growth rate of 7.3% and a median EBITDA growth rate of 33.82%.
Today's market reminds us of 1999 in many ways. REITs were hated. Tech was loved. But afterward, REITs strongly outperformed. Here's why it could happen again.
Rick Ducat turns to the healthcare sector on today's options analysis. He starts with the SPDR Health Care ETF (XLV), noting the recent breakdown of a head and shoulders pattern and potential for both bearish and bullish action ahead.
TSLW may face pressure as the "Big, Beautiful Bill" axed EV tax credits and slashed support for clean energy.